Filtros de búsqueda

Lista de obras de Toshiro Maekawa

A novel effect of parylene-based surface coating on HepG2 cell function

artículo científico publicado en 2014

A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.

artículo científico publicado en 2009

A single nucleotide polymorphism in activated Cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients.

artículo científico publicado en 2010

Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.

artículo científico publicado en 2009

Biochemical characterization of 60S acidic ribosomal P proteins associated with CK-II from bamboo shoots and potent inhibitors of their phosphorylation in vitro

artículo científico publicado en 1999

Biochemical characterization of HIV‐1 Rev as a potent activator of casein kinase II in vitro

artículo científico publicado el 29 de mayo de 1998

Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity potently inhibited by glycyrrhetinic acid derivative

artículo científico publicado en 1998

Casein kinase II inhibitors isolated from two Brazilian plants Hymenaea parvifolia and Wulffia baccata

artículo científico publicado en 1999

Characterization of human lactoferricin as a potent protein kinase CK2 activator regulated by A-kinase in vitro

artículo científico publicado en 2002

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

artículo científico publicado en 2010

Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection

artículo científico publicado en 2009

Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.

artículo científico publicado en 2006

IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.

artículo científico publicado en 2011

IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy.

artículo científico publicado en 2011

ITPA polymorphism affects ribavirin-induced anemia and outcomes of therapy--a genome-wide study of Japanese HCV virus patients.

artículo científico publicado en 2010

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.

artículo científico publicado en 2007

ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.

artículo científico publicado en 2010

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.

artículo científico publicado en 2010

Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C.

artículo científico publicado en 2012